1. Home
  2. XZO vs SLS Comparison

XZO vs SLS Comparison

Compare XZO & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exzeo Group Inc.

XZO

Exzeo Group Inc.

SELL

Current Price

$15.27

Market Cap

1.4B

Sector

Finance

ML Signal

SELL

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

SELL

Current Price

$13.90

Market Cap

1.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
XZO
SLS
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
XZO
SLS
Price
$15.27
$13.90
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$25.25
★ $37.50
AVG Volume (30 Days)
236.1K
★ 12.9M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
50.00
EPS
★ 0.73
N/A
Revenue
★ $216,980,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.64
N/A
P/E Ratio
$20.85
★ N/A
Revenue Growth
★ 61.99
N/A
52 Week Low
$12.36
$1.39
52 Week High
$24.60
$24.89

Technical Indicators

Market Signals
Indicator
XZO
SLS
Relative Strength Index (RSI) 37.56 60.23
Support Level $15.03 $9.36
Resistance Level $17.25 $15.77
Average True Range (ATR) 0.83 1.77
MACD -0.24 0.98
Stochastic Oscillator 3.11 43.49

Price Performance

Historical Comparison
XZO
SLS

About XZO Exzeo Group Inc.

Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: